Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized,Double-Blind Study of Gefitinib in Combination With Apatinib or Placebo in Previously Untreated Patients With EGFR Mutation-Positive Advanced Non-squamous Non-Small-Cell Lung Cancer

NCT02824458 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT02824458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02824458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized,Double-Blind Study of Gefitinib in Combination With Apatinib or Placebo in Previously Untreated Patients With EGFR Mutation-Positive Advanced Non-squamous Non-Small-Cell Lung Cancer
Lead sponsor
Sun Yat-sen University
Phase
Phase 3
Overall status
Unknown status
Start date
June 30, 2016
Completion date
December 31, 2023
Enrollment
246 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

egfr tyrosine kinase inhibitors plus vegfr inhibitors